Latest news
Zentalis Highlights Q2 Results and Azenosertib Progress - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 21:06:00 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:38:12 GMTZNTL: Clinical and regulatory progress advances, with $174.6M cash runway into late 2027 despite higher losses - TradingViewTradingView · Thu, 06 Aug 2026 09:02:20 GMTZNTL Q1 2026 Earnings: Wider loss fails to dampen investor sentiment on clinical progress - Earnings Call Q&A - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 01:31:15 GMTZNTL Q1 2026 Earnings: Wider loss fails to dampen investor sentiment on clinical progress - Revenue Warning Signal - dars.gov.etdars.gov.et · Tue, 28 Jul 2026 07:00:00 GMT